
Forward Pharma A/S
Forward Pharma A/S (FWPAY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fwpay · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Forward Pharma A/SYou FWPAY | $7M | 2118.18x | — | $0.00 |
Bionomics Limited BNOEF | $9M | N/A | — | -$1898.63 |
Carebook Technologies Inc. CRBKF | $7M | N/A | — | -$0.27 |
The Flowr Corporation FLWPF | $0M | N/A | — | -$0.23 |
HealthBeacon plc HBCNF | $8M | N/A | — | -$0.78 |
Immune Therapeutics, Inc. IMUN | $8M | N/A | — | -$0.16 |
Intellipharmaceutics International Inc. IPCIF | $5M | N/A | — | -$0.09 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Forward Pharma A/S (FWPAY) measures how much investors pay for each dollar of the company's trailing earnings. FWPAY's current PE ratio of 2118.18x is calculated by dividing its stock price of $300.00 by its TTM earnings per share of $0.00.
Frequently asked questions
FWPAY pe ratio · 6 questionsFWPAY's current PE ratio is 2118.18x as of 2026-06-10, based on a stock price of $300.00 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via FWPAY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Forward Pharma A/S SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10